MétaCan
Menu
Back to cohort
Record W2046262808 · doi:10.1016/j.jalz.2009.05.472

O3‐06‐07: GSI‐953 is a potent APP‐selective gamma‐secretase inhibitor for the treatment of Alzheimer's disease

2009· article· en· W2046262808 on OpenAlexaff
Steven J. Jacobsen, Thomas A. Comery, Anthony F. Kreft, Scott C. Mayer, Margaret M. Zaleska, David Riddell, Jonathan Bard, Cathleen Gonzales, Glen Frick, S. Bradley Forlow, Carrie Balliet, Michael E. Burczynski, Hong Wan, Boyd L. Harrison, Peter H. Reinhart, Menelas N. Pangalos, Robert Martone

Bibliographic record

VenueAlzheimer s & Dementia · 2009
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicProtein Hydrolysis and Bioactive Peptides
Canadian institutionsWomen's Health Research Institute
Fundersnot available
KeywordsGamma secretaseAmyloid precursor proteinNotch signaling pathwayAmyloid precursor protein secretaseChemistryIn vitroPharmacologyPresenilinCell biologyAlzheimer's diseaseBiochemistryReceptorBiologyInternal medicineMedicineDisease

Abstract

fetched live from OpenAlex

Gamma secretase is responsible for the intramembraneous cleavage of the Alzheimer's Precursor Protein (APP), the Notch receptor, and several other substrates. While inhibition of this protease results in potentially therapeutic reductions in the neurotoxic Abeta peptide, severe side effects might result from inhibiting Notch processing. We report a novel thiophene sulfonamide gamma-secretase inhibitor, GSI-953, that selectively inhibits cleavage of APP while sparing Notch processing. In vitro assays of Abeta production and Notch function, measurements of Abeta levels in plasma and brain of Tg2576 mouse, and assessments of cognitive function using the contextual fear conditioning model are described, as well as human plasma Abeta levels and initial biomarker data. This compound inhibits Abeta production with low nM potency in vitro in cellular and cell-free assays. Cellular assays of Notch cleavage reveal that this compound is >15-fold selective for the inhibition of APP cleavage. In the Tg2576 transgenic mouse, this compound causes a robust reduction in brain and plasma Abeta levels and reverses memory deficits that are correlated with Abeta load. A lowering of plasma Abeta levels in human demonstrates target engagement. These data demonstrate that GSI-953 is a potent and selective gamma-secretase inhibitor with potential for therapeutic utility in Alzheimer's Disease. For these reasons, GSI-953 has been advanced into human clinical trials.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.683
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.266
Teacher spread0.248 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations12
Published2009
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicProtein Hydrolysis and Bioactive PeptidesFrench-language works237,207